Comparative Meta-Analysis of Retatrutide Versus Placebo and Dulaglutide for Weight Loss and Diabetes Management: Insights From Clinical Trials.

Plain Language Summary

Comparative meta-analysis synthesizing randomized controlled trial data for retatrutide versus placebo and versus dulaglutide for weight loss and diabetes management. Quantitatively compares retatrutide's efficacy on HbA1c, body weight, fasting glucose, and safety endpoints across multiple trials. Confirms retatrutide's superior weight loss and glycemic control versus existing GLP-1 monotherapy.